Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6328126 | 0.97 | LMNA (0.38) | LMNA | |
| SCHEMBL3176852 | 0.97 | LMNA (0.38) | LMNA | |
| SCHEMBL7936584 | 0.97 | LMNA (0.38) | LMNA | |
| SCHEMBL949158 | 0.90 | — | — | |
| SCHEMBL2678911 | 0.88 | LMNA (0.30) | LMNA | |
| SCHEMBL7638924 | 0.83 | LMNA (0.42) | LMNA | |
| SCHEMBL1758916 | 0.83 | LMNA (0.35) | LMNA | |
| SCHEMBL1758393 | 0.80 | LMNA (0.33) | LMNA | |
| SCHEMBL6906883 | 0.78 | LMNA (0.32) | LMNA | |
| SCHEMBL8618375 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115028945-A | Synthetic method of polyvinylidene fluoride | 碧菲分离膜（大连）有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-117839447-A | Porous film | 东京应化工业株式会社 | 2024-04-09 | — | — | CN | disclosed |
| US-20230084014-A1 | SOFT WATER- AND OIL-REPELLENT COMPRISING FLUORINE-CONTAINING POLYMER AS ACTIVE INGREDIENT | UNIMATEC CO., LTD. (JP) | 2023-03-16 | — | — | US | disclosed |
| US-11574821-B2 | Substrate treating method, substrate treating liquid and substrate treating apparatus | SCREEN Holdings Co., Ltd. | 2023-02-07 | — | — | US | disclosed |
| EP-4105249-A1 | SOFT WATER- AND OIL-REPELLENT INCLUDING FLUORINE-CONTAINING POLYMER AS ACTIVE INGREDIENT | Unimatec Co., Ltd. (JP) | 2022-12-21 | — | — | EP | disclosed |
| CN-115028945-A | Synthetic method of polyvinylidene fluoride | 碧菲分离膜（大连）有限公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-115028945-A | Synthetic method of polyvinylidene fluoride | 碧菲分离膜（大连）有限公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-109309032-B | Substrate processing method and substrate processing apparatus | 株式会社斯库林集团 | 2022-07-15 | — | — | CN | disclosed |
| US-20220189762-A1 | SUBSTRATE PROCESSING METHOD AND SUBSTRATE PROCESSING APPARATUS | SCREEN Holdings Co., Ltd. (JP) | 2022-06-16 | — | — | US | disclosed |
| US-11302525-B2 | Substrate processing method and substrate processing apparatus | SCREEN Holdings Co., Ltd. | 2022-04-12 | — | — | US | disclosed |
| EP-2313365-A1 | AQUEOUS METHODS FOR MAKING FLUORINATED SULFONATE ESTERS | 3M Innovative Properties Company (US) | 2011-04-27 | — | — | EP | disclosed |
| WO-2010011454-A1 | AQUEOUS METHODS FOR MAKING FLUORINATED SULFONATE ESTERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-01-28 | — | — | WO | disclosed |
| EP-1828166-B1 | HYDANTOIN DERIVATIVES USEFUL AS METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2009-07-22 | — | — | EP | disclosed |
| US-20080280950-A1 | Hydantoin Derivatives Useful as Metalloproteinase Inhibitors | ASTRAZENECA AB (SE) | 2008-11-13 | — | — | US | disclosed |
| EP-1828166-A1 | HYDANTOIN DERIVATIVES USEFUL AS METALLOPROTEINASE INHIBITORS | AstraZeneca AB (SE) | 2007-09-05 | — | — | EP | disclosed |
| WO-2006064218-A1 | HYDANTOIN DERIVATIVES USEFUL AS METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | disclosed |
| US-5076956-A | Mixtures of fluorocarbons with alcohols, ethers, esters, ketones, nitrogen-containing organic compounds, and halogenated hydrocarbons | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-12-31 | — | — | US | disclosed |
| US-4115295-A | EPOXIDE FUNCTIONAL, HYDROXY FUNCTIONAL, DIELECTRICS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1978-09-19 | — | — | US | disclosed |
| US-4100134-A | Storage-stable epoxy-terminated silane prepolymer | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1978-07-11 | — | — | US | disclosed |
| US-4049861-A | EPOXY TERMINATED SILANES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1977-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080280950-A1 | Hydantoin Derivatives Useful as Metalloproteinase Inhibitors | MMP3, MMP9, MMP2 | LMNA 1052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.